These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22525081)

  • 21. Preclinical evaluation of dual action intranasal formulation intended for postoperative/cancer associated therapies.
    El-Setouhy DA; Ahmed S; Badawi AA; El-Nabarawi MA; Sallam N
    Eur J Pharm Sci; 2015 Aug; 76():48-56. PubMed ID: 25917526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ketorolac, an injectable nonnarcotic analgesic.
    Litvak KM; McEvoy GK
    Clin Pharm; 1990 Dec; 9(12):921-35. PubMed ID: 2292174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Acular LS in the pain management of keratoconus: a pilot study.
    Yu JO; Gundel RE
    Optom Vis Sci; 2010 Feb; 87(2):125-30. PubMed ID: 19996813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients.
    Solomon KD; Donnenfeld ED; Raizman M; Sandoval HP; Stern K; VanDenburgh A; Cheetham JK; Schiffman R;
    J Cataract Refract Surg; 2004 Aug; 30(8):1653-60. PubMed ID: 15313287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nasally inhaled pulsating aerosols: lung, sinus and nose deposition.
    Moller W; Saba GK; Haussinger K; Becker S; Keller M; Schuschnig U
    Rhinology; 2011 Aug; 49(3):286-91. PubMed ID: 21858257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of ketorolac tromethamine in horses after intravenous, intramuscular, and oral single-dose administration.
    Bianco AW; Constable PD; Cooper BR; Taylor SD
    J Vet Pharmacol Ther; 2016 Apr; 39(2):167-75. PubMed ID: 26416348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and evaluation of bioadhesive in-situ nasal gel of ketorolac tromethamine.
    Chelladurai S; Mishra M; Mishra B
    Chem Pharm Bull (Tokyo); 2008 Nov; 56(11):1596-9. PubMed ID: 18981612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of intravenous ketorolac tromethamine and morphine sulfate in the treatment of postoperative pain.
    Brown CR; Moodie JE; Wild VM; Bynum LJ
    Pharmacotherapy; 1990; 10(6 ( Pt 2)):116S-121S. PubMed ID: 2082307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ketorolac trometamol topical formulations: release behaviour, physical characterization, skin permeation, efficacy and gastric safety.
    El-Setouhy DA; El-Ashmony SM
    J Pharm Pharmacol; 2010 Jan; 62(1):25-34. PubMed ID: 20722996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous ketorolac tromethamine versus morphine sulfate in the treatment of immediate postoperative pain.
    Peirce RJ; Fragen RJ; Pemberton DM
    Pharmacotherapy; 1990; 10(6 ( Pt 2)):111S-115S. PubMed ID: 2082306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deposition pattern of nasal sprays in man.
    Newman SP; Morén F; Clarke SW
    Rhinology; 1988 Jun; 26(2):111-20. PubMed ID: 3175455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deposition pattern from a nasal pump spray.
    Newman SP; Morén F; Clarke SW
    Rhinology; 1987 Jun; 25(2):77-82. PubMed ID: 3616395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease.
    Lee RU; White AA; Ding D; Dursun AB; Woessner KM; Simon RA; Stevenson DD
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):130-5. PubMed ID: 20674823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bleeding risk with ketorolac after lumbar microdiscectomy.
    Chin KR; Sundram H; Marcotte P
    J Spinal Disord Tech; 2007 Apr; 20(2):123-6. PubMed ID: 17414980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paracetamol and ketorolac pharmacokinetics and metabolism at delivery and during postpartum.
    Allegaert K; van Calsteren K; Hendrickx S; Kelchtermans J; Smits A; Kulo A; van de Velde M
    Acta Anaesthesiol Belg; 2012; 63(3):121-5. PubMed ID: 23397664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and in vitro evaluations of gelatin A microspheres of ketorolac tromethamine for intranasal administration.
    Sankar C; Mishra B
    Acta Pharm; 2003 Jun; 53(2):101-10. PubMed ID: 14764244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postoperative ketorolac tromethamine use in infants aged 6-18 months: the effect on morphine usage, safety assessment, and stereo-specific pharmacokinetics.
    Lynn AM; Bradford H; Kantor ED; Seng KY; Salinger DH; Chen J; Ellenbogen RG; Vicini P; Anderson GD
    Anesth Analg; 2007 May; 104(5):1040-51, tables of contents. PubMed ID: 17456651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of preservative, antioxidant and viscolizing agents on in vitro transcorneal permeation of ketorolac tromethamine.
    Malhotra M; Majumdar DK
    Indian J Exp Biol; 2002 May; 40(5):555-9. PubMed ID: 12622201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation and pharmacokinetics of ketorolac tromethamine fast dissolving tablets.
    Mettu SR; Veerareddy PR
    Drug Res (Stuttg); 2013 Nov; 63(11):586-90. PubMed ID: 23780501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals.
    Mroszczak EJ; Jung D; Yee J; Bynum L; Sevelius H; Massey I
    Pharmacotherapy; 1990; 10(6 ( Pt 2)):33S-39S. PubMed ID: 2082311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.